A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)

NCT03992430 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Muscular Dystrophy, Duchenne

Interventions

DRUG: Eteplirsen

Sponsor

Sarepta Therapeutics, Inc.